Postischemic synthesis of high energy phosphates in isolated porcine hearts during reperfusion with 11 or 25°C hypothermic perfluorocarbon emulsion FC 43. A 31P magnetic resonance spectroscopy study

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 4, 1997, Pages 746-750

  Scheule, Albertus M ^a   Bohl, Axel ^b   Heinemann, Markus K ^a   Ziemer, Gerhard ^a   Henze, Eberhard ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Artificial oxygen carrier; Cardiac ischemia; Heart preservation; Myocardial metabolism; Perfluorcarbon emulsion

Indexed keywords

FLUOROCARBON; PERFLUOROTRIBUTYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMULSION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORGAN PRESERVATION; PRIORITY JOURNAL; SWINE;

ANIMALS; BLOOD SUBSTITUTES; ENERGY METABOLISM; FLUOROCARBONS; HYPOTHERMIA, INDUCED; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHATES; PHOSPHOCREATINE; SWINE;

EID: 0030936519     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)01100-1     Document Type: Article

References (26)

1. Aoki M, Nomura F, Mayer, JE Jr. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart. J Thorac Cardiovasc Surg 1994;107(3):822-828.
2. Belzer FO, Southard HH. Principles of organ preservation by cold storage. Transplant 1988;45(4):673-676.
3. Breuninger HG, Rubenstein SD, Wolfson MR, Schaffer TH. Effect of exchange transfusion with a red blood cell substitute on hemodynamics and organ blood flows. J Pediatr Surg 1993;28(2):144-150.
4. Brinkmann G, Burkhart C, Clausen M, Henze E. The effect of Belzer and Bretschneider cardioplegia solutions on myocardial energy metabolism. A study with phosphorus magnetic resonance spectroscopy in an animal model. Z Kardiol 1992;81(6):339-344.
5. Fuchinoue S, Teraoka S, Honda H et al. Evaluation of intracellular energy status during liver preservation by 31P-NMR spectroscopy. Transplant Proc 1987;19(5):4116-4121.
6. Grünert J. Physikalische und technische Grundlagen der MR-Spektroskopie. MR-Spektroskopie. Deutscher Ärzteverlag Köln, 1989:11-40.
7. Heldmaier G, Ruf T. Body temperature and metabolic rate during natural hypothermia in endotherms. J Comp Physiol B 1992;162(8):696-706.
8. Henze E, Schoser K, Lietzenmeyer R et al. Studies of myocardial metabolism using P-31 NMR spectroscopy and a simple perfusion model of slaughtered animals - an approach to avoid in vivo animal experiments. Z Kardiol 1989;78(9):553-560.
9. Henze E, Lietzenmayer R, Kunz R et al. Prerequisites and initial experience for the noninvasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy. Transplant Proc 1990;22(5):2404-2408.
10. Hicks GL, Arnold W, DeWall RA. Fluorcarbon cardioplegia and myocardial protection. Ann Thorac Surg 1983;35(5):500-503.
11. Kiricuta IC, Schmitt W, Beyer HK. Possibilities of phosphorus 31 spectroscopy in assessing the therapeutic effects on cellular energy metabolism of the myocardium. Herz 1989;14(3):260-266.
12. Pearl JM, Laks H, Drinkwater DC et al. Fluosol cardioplegia results in complete functional recovery: a comparison with blood cardiopegia. Ann Thorac Surg 1992;54(6):1144-1150.
13. Ravis WR, Hoke JF, Parsons DL. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination. Drug Metab Rev 1991;23(3-4):375-411.
14. Robitaille PM, Merkle H, Sako E et al. Measurement of ATP synthesis rates by 31P-NMR spectroscopy in the intact myocardium in-vivo. Magn Reson Med 1990;15(1):8-24.
15. Saeed M, Wendland MF, Wagner S, Derugin N, Higgins CB. Preservation of high-energy phosphate reserves in cat model of post-ischemic myocardial dysfunction. Invest Radiol 1992; 27(2):145-152.
16. Sakai H. Mechanism of myocardial ischemic injury assessed by phosphorus-31 magnetic resonance spectroscopy (effect of catecholamine on ischemic hearts). Osaka City Med J 1990;36(1):1-20.
17. Schaefer S, Camacho SA, Gober J et al. Response of myocardial metabolites to graded regional ischemia: 31P NMR spectroscopy of porcine myocardium in-vivo. Circ Res 1989;64(5):968-976.
18. Schaefer S, Massie B, Weiner MW. Magnetic resonance spectroscopy of the heart. Cardiol Clin 1989;7(3):697-712.
19. Scheule A, Bohl A, Clausen M, Henze E. The synthesis of high energy phosphates during reperfusion with hypothermic perfluorocarbon emulsion FC43-A studied with 31P MRS using a model of isolated porcine hearts. Z HTG-Chir 1993;7:233-238.
20. Segel LD, Minten JM, Schweighardt FK. Fluorochemical emulsion APE-LM substantially improves cardiac preservation. Am J Physiol 1992;263(3PT2):H730-739.
21. Segel LD, Follette DM, Iguidbashian JP et al. Posttransplantation function of hearts preserved with fluorochemical emulsion. J Heart Lung Transplant 1994;13(4):669-680.
22. Tabayashi K, Mc Koewn PP, Miyamoto M et al. Ischemic myocardial protection - comparison of nonoxygenated crystalloid, oxygenated crystalloid and oxygenated fluorcarbon cardioplegic solutions. J Thorac Cardiovasc Surg 1988;95(2):239-246.
23. Ueda K, Genda T, Hirata I et al. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart. J Heart Lung Transplant 1992;11(4PT1):646-655.
24. Whitman GJ, Roth RA, Kieval RS, Harken AH. Evaluation of myocardial preservation using 31P NMR. J Surg Res 1989; 38(2):154-161.
25. Yanagi S, Takeuchi K, Takeda T, Ishikawa M, Miura I. Effects of inotropic stimulation on phosphate compounds in ischemic canine hearts. Cardiovasc Res 1993;27(8):1435-1443.
26. Yau TM, Ikonomidis JS, Weisel RD et al. Which techniques of cardioplegia prevent ischemia? Ann Thorac Surg 1993;56(5): 1020-1028.